Gunderson Capital Management Inc. Edwards Lifesciences Corp Transaction History

Gunderson Capital Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$52.41 - $81.0 $1.05 Million - $1.63 Million	-20,129 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$71.7 - $82.09 $40,940 - $46,873	-571 Reduced 2.76%	20,129 $4.7 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $62,042 - $76,033	-1,008 Reduced 4.64%	20,700 $4.55 Million
Q2 2019 Nov 14, 2019	SELL	$55.74 - $64.41 $68,225 - $78,837	-1,224 Reduced 5.34%	21,708 $4.01 Million
Q1 2019 Nov 14, 2019	BUY	$47.89 - $64.05 $138,449 - $185,168	2,891 Added 14.43%	22,932 $4.39 Million
Q4 2018 Nov 14, 2019	BUY	$46.41 - $56.94 $930,102 - $1.14 Million	20,041 New	20,041 $3.07 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Gunderson Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gunderson Capital Management Inc. with notifications on news.